Compare LESL & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LESL | TRIB |
|---|---|---|
| Founded | 1963 | 1992 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.7M | 18.6M |
| IPO Year | 2020 | N/A |
| Metric | LESL | TRIB |
|---|---|---|
| Price | $1.73 | $0.92 |
| Analyst Decision | Hold | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $14.97 | N/A |
| AVG Volume (30 Days) | 182.8K | ★ 404.6K |
| Earning Date | 02-06-2026 | 02-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,241,915,000.00 | $48,570,000.00 |
| Revenue This Year | N/A | $13.51 |
| Revenue Next Year | $2.09 | $13.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.51 | $0.48 |
| 52 Week High | $46.40 | $3.44 |
| Indicator | LESL | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 43.16 | 57.29 |
| Support Level | $1.55 | $0.66 |
| Resistance Level | $1.82 | $0.95 |
| Average True Range (ATR) | 0.14 | 0.06 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 48.78 | 87.67 |
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products, including chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company serves residential pool, residential spa, professional pool, and commercial pool consumers and markets its products through over 1,000 company-operated locations in 39 states and e-commerce websites, operating only in the United States. It operates mainly in the pool and spa aftermarket industry and offers regularly purchased, non-discretionary maintenance items, along with installation and repair services for pool and spa equipment.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.